Correction to: Preclinical Evaluation and Dosimetry of [111In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)

Correction to: Preclinical Evaluation and Dosimetry of [¹¹¹In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)

Mol Imaging Biol. 2020 Aug;22(4):992. doi: 10.1007/s11307-020-01493-w.

¹ Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. f.cicone@iol.it.
² Unit of Nuclear Medicine, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Catanzaro, Italy. f.cicone@iol.it.
³ Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁴ Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁵ Experimental Pathology Service, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁶ Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne, CH-1066, Epalinges, Switzerland.

In the original article, some numerical values in the following paragraph were reported incorrectly.